Table 1 Characteristics, details, and outcomes of the five cases.
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
|---|---|---|---|---|---|
| Age (years) | 76 | 75 | 70 | 70 | 75 |
| Sex | Male | Male | Male | Male | Female |
| Chief complaint | Hematemesis | Hematemesis | Hematemesis | Fever | Anorexia |
| Medical history | HT | HT, DL, DM, CKD, AP | HT, DL, AP | HT, SSS (p-PCI) | IE, Cerebral Infarction, AF, HT, HUA |
| Operation history | Juxta-renal AAA replacement | Infra-renal AAA replacement | Infra-renal AAA replacement | Infra-renal AAA replacement | Infra-renal mycotic AAA replacement |
| Duration from the primary surgery (year) | 6.5 | 2.75 | 5 | 3.3 | 1.5 |
| Pathology | AEnF | AEnF | AEnF | AEnE | AEnE |
| 1st intervention | Partial graft replacement (Reconstruction of CeA/SMA/RA), Partial duodenectomy | EVAR | EVAR | Partial graft replacement with rifampicin-soaked graft, Partial duodenectomy | Partial graft replacement with rifampicin-soaked graft, Partial duodenectomy |
| Interval until radical surgery (day) | 0 | 86 | 32 | 35 | 20 |
| Detected bacteria | Streptococcus anginosus | Granulicatella adiacens, Staphylococcus epidermis *MRS, Corynebacterium spp., Enterococcus faecium | Staphylococcus aureus *MRSA | Staphylococcus epidermis *MRS, Leuconostoc species | Olsenella uli, Slackia exigua, Atopobium parvulum |
| Detected fungus | — | Candida albicans | — | Candida albicans | — |
| Intravenous antibiotics | TAZ/PIPC | MEPM, VCM | — | TAZ/PIPC, MEPM | MEPM, VCM |
| Oral antibiotics | AMPC | — | LZD, ST | AMPC | — |
| Antifungal drug | — | MCFG | — | MCFG, FLCZ | — |
| Complication | Cholecystitis Duodenum sutural insufficiency | Graft infection | None | None | Intramuscular abscess |
| Length of stay (day) | 59 | 150 | 110 | 82 | 35 |
| Outcome | Survived | Died | Survived | Survived | Survived |
| Cause of death | — | Sepsis | — | — | — |
HT: hypertension; DL: dyslipidemia; DM: diabetes mellitus; CKD: chronic kidney disease; AP: angina pectoris; SSS: sick sinus syndrome; p-PCI: postpercuta- neous coronary intervention; IE: infective endocarditis; AF: atrial fibrillation; HUA: hyperuricemia; AAA: abdominal aorta aneurysm; AEnF: aortoenteric fistula; AEnE: aortoenteric erosion; CeA: celiac artery; SMA: superior mesenteric artery; RA: renal artery; EVAR: endovascular aortic repair; *MRS: methicillin-resistant staphylococci; MRSA: methicillin-resistant staphylococcus aureus; TAZ/PIPC: tazobactam/piperacillin; MEPM: meropenem; VCM: vancomycin; DAP: daptomycin; TEIC: teicoplanin; LZD: linezolid; AMPC: amoxicillin; ST: sulfa/trimethoprim; MCFG: micafungin; FLCZ, fluconazole